Jason P Rhodes's Net Worth
Jason P Rhodes's net worth is estimated to be at least $67,229,099.97 as of 05/10/2024. CoreStreet's estimation of Jason P Rhodes's net worth is based on their sale of stock and current holding of stock.
Jason P Rhodes is Director at Dyne Therapeutics Inc. They have executed at least 25 trades of stock as per SEC Form 4 filings. Their most recent trade was for 190,920 units of DYN stock on 02/28/2024. Their biggest sale was on 02/26/2024 when they sold 248,219 units of Dyne Therapeutics Inc stock for $5,887,754.68. They typically trade 4 times per year.
Total value of insider buys:
- $25,022,316.70
Total value of insider sells:
- $42,206,783.27
Most recent insider trade:
- Feb. 28, 2024
Jason P Rhodes's Insider Trading History
| Dyne Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 28, 2024 | Director | 190,920 | $24.84 | Sell | $4,742,452.80 |
Feb. 26, 2024 | Director | 248,219 | $23.72 | Sell | $5,887,754.68 |
Feb. 22, 2024 | Director | 119,360 | $22.66 | Sell | $2,704,697.60 |
Feb. 20, 2024 | Director | 169,539 | $22.72 | Sell | $3,851,926.08 |
Feb. 15, 2024 | Director | 177,906 | $23.89 | Sell | $4,250,174.34 |
Dec. 12, 2022 | Director | 934,581 | $10.70 | Buy | $10,000,016.70 |
| Generation Bio Co | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 29, 2021 | Director | 16,586 | $24.59 | Sell | $407,849.74 |
Sept. 27, 2021 | Director | 51,389 | $25.70 | Sell | $1,320,697.30 |
Sept. 24, 2021 | Director | 28,916 | $25.84 | Sell | $747,189.44 |
Sept. 22, 2021 | Director | 30,617 | $25.89 | Sell | $792,674.13 |
June 23, 2021 | Director | 62,609 | $25.36 | Sell | $1,587,764.24 |
June 21, 2021 | Director | 63,892 | $24.84 | Sell | $1,587,077.28 |
April 14, 2021 | Director | 23,413 | $26.61 | Sell | $623,019.93 |
April 12, 2021 | Director | 74,124 | $26.15 | Sell | $1,938,342.60 |
April 8, 2021 | Director | 43,550 | $28.50 | Sell | $1,241,175.00 |
| Replimune Group Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 18, 2020 | Director | 4,319 | $41.95 | Sell | $181,182.05 |
Dec. 16, 2020 | Director | 12,675 | $42.13 | Sell | $533,997.75 |
Dec. 14, 2020 | Director | 37,659 | $43.49 | Sell | $1,637,789.91 |
Dec. 11, 2020 | Director | 31,636 | $43.38 | Sell | $1,372,369.68 |
Dec. 9, 2020 | Director | 41,216 | $43.77 | Sell | $1,804,024.32 |
Dec. 7, 2020 | Director | 67,890 | $45.96 | Sell | $3,120,224.40 |
Nov. 18, 2019 | Director | 1,100,000 | $13.61 | Buy | $14,971,000.00 |
Nov. 15, 2019 | CEO | 15,000 | $3.42 | Buy | $51,300.00 |
| Epizyme Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 4, 2014 | CFO | 30,000 | $29.74 | Sell | $892,200.00 |
July 7, 2014 | CFO | 30,000 | $32.74 | Sell | $982,200.00 |